Four different compositions of polylactide/thermoplastic starch blends (PLA/TPS blends) for application as drug carriers were examined. Initially, using cyanocobalamin (1.355 kDa) as a model compound, the blend with the highest starch content (wt. 60%) was selected for further research of mass transfer phenomenon. In this case, different concentrations of acetaminophen (0.151 kDa), doxorubicin hydrochloride (0.580 kDa) and cyanocobalamin (1.355 kDa) were used for determination of particular releasing profi les. Besides from the comparative analysis of obtained results, the values of the overall mass transfer coeffi cient (K) were calculated for each of tested drug molecules. Depending on the size and properties of used compound, determined values of the coeffi cient range from 10 -11 to 10 -13 m/s. Based on these outcomes, it could be stated that PLA/TPS blend selected in preliminary research, seems to be preferred material for fabrication of long-term drug delivery systems, which could be successfully applied for example in anti-cancer therapy.
INTRODUCTION
Biodegradable polymers represent diverse group of eligible materials (e.g. poly(lactic acid) (PLA), poly(glycolic acid) (PGA), poly(ε-caprolactone) (PCL), poly(L-glutamic acid) (PLG), poly(L-lysine) (PLL), polyphosphoesters (PPEs), chitosan, starch, gelatin and others)
1, 2
, which play an increasingly signifi cant role in dynamic biotechnological advancements. Thanks to their unique degradability and biocompatibility properties, they become materials of interest, used particularly for medical and pharmaceutical technology purposes
. The fi rst medical application of biodegradable polymers dates back to seventies of the last century when poly(glycolic acid), poly(lactic acid) and their copolymers were developed to use as absorbable surgical sutures 3, 4 . Since then, biodegradable polymers have been intensively explored and considered as prominent functional materials developed in various medical fi elds, such as tissue engineering
5, 6
, implantology 7 , surgery 8, 9 and drug delivery 10, 11
. In particular, due to ability to undergo decomposition inside the body resulting in non-toxic byproducts (e.g. water, carbon dioxide), they are favorable matrices for the fabrication of drug delivery systems 12 . In regard to environmental law restrictions and sophisticated demands of food, medical and pharmaceutical industries, rapidly growing interest in the use of biodegradable polymers, obtained from renewable resources is observed 13- 15 . In this case, ones of the most promising are polylactide 16 and starch 17 . Polylactide (PLA), an aliphatic polyester and biocompatible thermoplastic, is currently one of the widely studied 'green' eco-friendly polymer produced from the renewable raw materials. PLA is considered as one of the most popular biodegradable polymer with the extensive development prospects 18, 19 . The presence of the ester bond in the PLA structure determines its high elasticity, which enable its decomposition under different pH conditions into non-toxic compounds. The total biodegradation of the PLA ranges from six months to two years 20 . In order to improve PLA properties (e.g. stiffness, permeability, crystallinity and thermal stability), it could be proceed blending with various compounds (mono-or polymers)
21 . Due to their ability to fulfi ll complex requirements, typically including properties such as: biocompatibility, biodegradability, mechanical strength and processability, polylactide homo-, copolymers and blends have become the materials of choice especially in biomedical applications 22 . Starch, a natural polysaccharide widely occurred in plants (e.g. potato, maize, wheat), is one of the most abundant, cheap and readily available raw material derived from renewable resources. In native form, starch forms granular structure mostly composed of linear amylose and highly branched amylopectin 23 . When subjected to thermal extrusion process in the presence of plasticizers (e.g. glycerol), starch undergo destructurization resulting in homogeneous melt known as thermoplastic starch (TPS)
24-26
. TPS is compatible with the environment. Moreover, due to its biodegradability, low cost and wide availability it is mainly used as a cheap fi ller for biodegradable polymers
27
. In this fi eld, the preparation, characterization and application of polylactide/thermoplastic starch blends are subjected to dynamically developing research 28, 29 . The main aim of the study was to verify the potential predisposition of different PLA/TPS blends for application as drug carriers. In this case, the molecule diffusion was considered as a drug release strategy
30, 31
. In preliminary studies, four materials with different PLA:TPS ratio were examined using cyanocobalamin as a model bioactive compound. Next, detailed mass transport studies were made for one selected material with PLA:TPS ratio 2:3 (wt.%). In this case, acetaminophen (0.151 kDa), doxorubicin hydrochloride (0.580 kDa) and cyanocobalamin (1.355 kDa) were used as model-size drugs molecules and the values of diffusion coeffi cient for each of them were experimentally estimated.
MATERIAL AND METHODS

Material
Polylactide (PLA Ingeo TM Biopolymer 2003D) in pelleted form was supplied by NatureWorks (USA). Native potato starch (initial moisture content 12-15%) was obtained from Trzemeszno Sp. z o.o. Potato Industry Company (Poland). Glycerol (99.5% purity) was purchased from Brenntag (Poland). Rapeseed oil and beeswax were purchased from local producers (Poland). Acetaminophen (molecular weight, M = 0.151 kDa), cyanocobalamin (molecular weight, M = 1.355 kDa) and methanol were supplied by Sigma Aldrich (Germany). Doxorubicin hydrochloride (molecular weight, M = 0.580 kDa) was obtained from Fluorochem Ltd (UK). The other reagents, all of analytical grade, were purchased from Avantor Performance Materials (Poland).
Methods
Preparation of thermoplastic starch (TPS) and PLA/ TPS blends
Potato starch was dried to 8-9% moisture content and mixed with or without some processing additives (oil, wax) and glycerol as plasticizer using high speed mixer (Labtech Engineering, Thailand). The amount of oil and wax was 1.0 wt.% and 0.5 wt.% on the dry weight basis of starch, respectively. Starch with other additives were processed using co-rotating twin-screw extruder (Labtech Engineering, Thailand) with screw diameter D = 20 mm with L:D ratio 48:1 using barrel temperature in the range 70°C-140°C and at 100 rpm screw speed to obtain thermoplastic starch (TPS)
32
. The extrusion temperature profi le for thermoplastic starch plasticized by glycerol from feed section to melting section was 70/90/120/130/140/140 /140/140/135/125/115/110 o C. Threads of thermoplastic materials coming out of extruder die were cooled with air and then granulated. The obtained TPS was used in preparation of blends with PLA in the next step.
The PLA/TPS blends were also prepared in extrusion process using co-rotating twin screw extruder (Labtech Engineering, Thailand) (150°C-175°C, 100 rpm). In this case, the ratios of PLA:TPS equal to 1:1 and 2:3 with different additives oil, wax were used.
Preparation of PLA/TPS fi lms
The obtained PLA/TPS blends in granulates form were blown using a single-screw extruder (Labtech Engineering) with screw diameter D = 20 mm (L:D = 30:1) connected to blown fi lm unit (LF-250-COEX, Labtech Engineering) with ring-shaped die to prepare biodegradable fi lms. The blown fi lm extrusion process was carried out at temperature range from 155°C to 175°C and screw speed of 44 rpm. The thickness of prepared fi lms was in the range 50-90 mm.
Mechanical properties of PLA/TPS fi lms
The mechanical properties including tensile strength and elongation at break of the materials were determined using universal testing machine Instron 3340 according to the ISO 527 standard with a crosshead speed of 100 mm/min and load cell capacity of 5 kN. For this purpose, the blown fi lms were cut into 15 mm wide strip samples. Thickness of fi lms was determined with thickness gauge in fi ve places along the sample and arithmetic mean was set to determine tensile properties. The values of tensile strength at break (σ) and elongation at break (ε) were determined using 12 individual samples. Then, the arithmetic mean of 10 results was obtained (two extreme results were rejected).
Preliminary studies of PLA/TPS blends transport properties
Prior to the main studies, PLA/TPS fi lms (50-90 μm) were hydrophilized for 24 h with 70 vol.% aqueous solution of methanol. In order to verify the permeation properties of tested materials, the cyanocobalamin (1.355 kDa) was used as a model bioactive compound. Briefl y, the pouches (30 x 75 mm) prepared from the PLA/TPS fi lms were fi lled in with appropriate concentration of cyanocobalamin prepared in 10 vol.% methanol and tightly closed with plastic clamp. The experiment was initiated by inserting the pouch fi lled with cyanocobalamin solution into the beaker, containing the receiving medium 
Mass transfer studies through the fi lm barrier composed of PLA and TPS in a 2:3 ratio
Prior to the mass transfer studies, PLA/TPS fi lms (50-90 μm) were hydrophilized for 24 h with 70 vol.% aqueous solution of methanol. Initially, the general permeability properties of this material were tested using bioactive compounds of different molecular weights ranging from 0.151 to 66 kDa (acetaminophen -0.151 kDa, doxorubicin hydrochloride -0.580 kDa, cyanocobalamin -1.355 kDa, trypsin -23.8 kDa, bovine serum albumin -66.0 kDa). The experiments were carried out for 15 days in Ringer's solution at ambient temperature.
In order to investigate the mass transfer phenomena across chosen polymeric barrier, three model drugs molecules of different molecular weight (acetaminophen -0.151 kDa, doxorubicin hydrochloride -0.580 kDa, cyanocobalamin -1.355 kDa) were used. Briefl y, the pouches (40 x 80 mm) prepared from the fi lms with PLA:TPS ratio 2:3 (wt.%) were washed out twice with Ringer's solution and after drying, they were fi lled with the solution of a model drug at the appropriate concentration and then tightly closed with plastic clamps. Each experiment was started by inserting the pouch with the solution of the model bioactive compound into the beaker containing the receiving medium (Ringer's solution). The releasing rate of each tested compound from the PLA/ TPS reservoir was monitored by measuring changes in absorbance (at the specifi ed wavelength) in a receiving solution. Consecutively, releasing of acetaminophen was monitored at 240 nm using standard curve C acetaminophe- The overall mass transfer coeffi cient was determined using equation (1) 
RESULTS AND DISCUSSION
Preliminary research
The blends of polylactide (PLA) and thermoplastic starch (TPS) in form of thin fi lm were prepared in singlescrew extrusion process. The PLA/TPS materials used in present study were manufactured in the Department of Organic Technologies of New Chemical Syntheses Institute (Puławy, Poland) and details of their production procedure are protected by rigorous technological confi dentiality requirements. The composition of obtained PLA/TPS materials and their mechanical properties are shown in Table 1 .
The values of tensile strength at break and elongation at break of commercial polylactide are 70.1 MPa and 9.6%, respectively. The TPS addition into the PLA matrix causes an increase of ε value by over 200% compared to pure polylactide and leads to obtain fl exible fi lms. On the other hand, the tensile strength of polylactide was decreased after TPS addition. The cause is low tensile properties of thermoplastic starch -typically below 6 MPa in tensile strength 34 . Furthermore, it is well known that hydrophilic starch and hydrophobic polylactide more common forms incompatible blends than compatible.
The incompatibility results in deterioration of blends mechanical properties. The incorporation of wax improved strength at break (38.7 MPa) and decrease elongation at break (4.6%) of PLA/TPS fi lm compared to other samples. These results suggest that the movements of the blend molecules restricted after wax incorporation into the polymer matrix. Moreover low elongation at break value of sample (1) suggest that is quite brittle, thus low content of wax could lead to antiplasticization effects. The interactions between starch and wax molecules were not observed in infrared spectroscopy. The FTIR spectra Table 1 . Formulation, mechanical properties and the percent of released mass of cyanocobalamin from containers made of PLA/ TPS blends with different composition; initial concentration of cyanocobalamin 1.63 g/L, ambient temperature, 10 vol.% methanol in water as receiver solution of thermoplastic starch plasticized by glycerol or mixture of glycerol with additives are analogous, therefore the spectra presentation was omitted. In order to verify the permeation properties of the tested materials, the preliminary experiments were carried out using cyanocobalamin (1.355 kDa) as a model compound and 10% methanol as solution (the permeability increases with an alcohol contain). The results of these experiments are depicted in Table 1 . Due to these data, materials 2, 3 and 4 were chosen for the studies in water (Fig. 1) .
The mass transport of the model compound in water through PLA/TPS fi lms 2 and 4 was alarmingly too slow. Therefore, in aspect of long-term drug therapy, the most suitable values of released cyanocobalamin were obtained for blend 3 produced at the PLA:TPS ratio 2:3 and this material was subjected to further research.
Mass transfer studies of model drugs
The PLA/TPS blend selected in preliminary research was subjected to more detailed studies. Initially, the general permeability properties of this material were tested using bioactive compounds of different molecular weight ranging from 0.151 to 66 kDa. The experiments were carried out in ambient temperature for 15 days. It was observed that the blend consisting of PLA and TPS in a ratio of 2:3 wt.% was well permeable to molecules below 2.0 kDa (the typical drug molecules sizes) and completely impermeable to compounds of weight above 20 kDa (the value corresponding to immune response proteins). Due to obtained results three model drug molecules (acetaminophen -0.151 kDa, doxorubicin hydrochloride -0.580 kDa and cyanocobalamin -1.355 kDa) were chosen for further studies of mass transfer phenomena.
Considering biomedical applications of the PLA/TPS materials as drug carriers, the precise determination of the individual release profi les and detailed descriptions of those processes are crucial. Therefore, in order to determine the release progress and calculation of the overall mass transfer coeffi cients, each of the model compounds was tested at four different concentrations. Acetaminophen and doxorubicin were used in a range of about 0.02-0.28 g/L, whereas in case of cyanocobalamin, thanks to its good solubility, higher concentrations (~0.28-2.30 g/L) were tested. All release processes were performed under conditions simulating the physiological environment of the human body fl uids (Ringer's solution, 37°C). The results are depicted in Figure 2 .
As expected, it was noticed that release progress proceeded slowest for the largest model molecule tested in this study (Fig. 2c, cyanocobalamin) . By comparing the results obtained after 24 h of release process for similar initial concentrations of applied drugs (Fig. 2 a (•) ,b (•) c (Δ)) it was observed that in case of acetaminophen and doxorubicin the amount of released mass was respectively over sixfold and twice higher than for cyanocobalamin. Subsequently, for each tested compound, the overall mass transfer coeffi cient was determined (Table 2) .
Obtained values of K vary between 10 -11 and 10 -13 m/s, what properly correspond to weeks long therapy time 31, 35 . The result for cyanocobalamin entrapped in PLA/TPS fi lm (K = 3.996
. 10 -13 m/s) could be directly compared with those obtained in previous work
31
. The overall mass transfer coeffi cients determined for cyanocobalamin immobilized in alginate capsules covered with polyethersulfone, polysulfone or cellulose acetate semi-permeable membrane was equal to 3.611 . 10 -9 , 1.600
. 10 -9 and 9.028 . 10 -8 respectively 31 . In this case, mass transfer across PLA/TPS fi lm barrier is 4-5 orders of magnitude lower. It's an important advantage in a long-term medical therapy.
CONCLUSION
Both polylactide (PLA) and thermoplastic starch (TPS) from chemical point of view are characterized by good biocompatibility and biodegradability, which makes them a subject of great interest for pharmaceutical and medical applications. The main aim of the study was to verify potential predisposition of different PLA/TPS blends for application as drug carriers. In this case, after a preliminary examination of permeable properties, a fi lm composed of PLA and TPS in a 2:3 ratio was selected from the group of four materials varied in the content of particular building blocks. Subsequently, this mate- rial was subjected to detailed research of mass transfer phenomenon using three model bioactive compounds varied in molecular weight (0.151-1.355 kDa). Obtained values of the overall mass transfer coeffi cient are in the range from 10 -11 to 10 -13 m/s (depending on the size and properties of used compound).
Summarizing experimental research performed in current study, it could be stated that the blend composed of PLA and TPS in 2:3 wt.% ratio, seems to be promising material for the fabrication of effi cient prolonged drug release systems, which could be successfully applied for example in anti-cancer therapy.
